دورية أكاديمية

Synaptic Plasticity Dysfunctions in the Pathophysiology of 22q11 Deletion Syndrome: Is There a Role for Astrocytes?

التفاصيل البيبلوغرافية
العنوان: Synaptic Plasticity Dysfunctions in the Pathophysiology of 22q11 Deletion Syndrome: Is There a Role for Astrocytes?
المؤلفون: de Oliveira Figueiredo EC; Department of Fundamental Neurosciences, University of Lausanne, 1005 Lausanne, Switzerland., Bondiolotti BM; Department of Fundamental Neurosciences, University of Lausanne, 1005 Lausanne, Switzerland., Laugeray A; Department of Fundamental Neurosciences, University of Lausanne, 1005 Lausanne, Switzerland., Bezzi P; Department of Fundamental Neurosciences, University of Lausanne, 1005 Lausanne, Switzerland.; Department of Pharmacology and Physiology, University of Rome Sapienza, 00185 Rome, Italy.
المصدر: International journal of molecular sciences [Int J Mol Sci] 2022 Apr 16; Vol. 23 (8). Date of Electronic Publication: 2022 Apr 16.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI, [2000-
مواضيع طبية MeSH: 22q11 Deletion Syndrome*/genetics , 22q11 Deletion Syndrome*/metabolism , Astrocytes*/metabolism, Animals ; Humans ; Mice ; Mitochondria/genetics ; Mitochondria/metabolism ; Mitochondrial Proteins/metabolism ; Neuronal Plasticity/genetics
مستخلص: The 22q11 deletion syndrome (DS) is the most common microdeletion syndrome in humans and gives a high probability of developing psychiatric disorders. Synaptic and neuronal malfunctions appear to be at the core of the symptoms presented by patients. In fact, it has long been suggested that the behavioural and cognitive impairments observed in 22q11DS are probably due to alterations in the mechanisms regulating synaptic function and plasticity. Often, synaptic changes are related to structural and functional changes observed in patients with cognitive dysfunctions, therefore suggesting that synaptic plasticity has a crucial role in the pathophysiology of the syndrome. Most interestingly, among the genes deleted in 22q11DS, six encode for mitochondrial proteins that, in mouse models, are highly expressed just after birth, when active synaptogenesis occurs, therefore indicating that mitochondrial processes are strictly related to synapse formation and maintenance of a correct synaptic signalling. Because correct synaptic functioning, not only requires correct neuronal function and metabolism, but also needs the active contribution of astrocytes, we summarize in this review recent studies showing the involvement of synaptic plasticity in the pathophysiology of 22q11DS and we discuss the relevance of mitochondria in these processes and the possible involvement of astrocytes.
References: Cell Mol Neurobiol. 2002 Jun;22(3):259-67. (PMID: 12469869)
Eur J Neurosci. 2002 Jan;15(2):246-56. (PMID: 11849292)
Neuroscience. 2009 Nov 24;164(1):72-87. (PMID: 19446012)
Neuron. 2016 Jan 6;89(1):163-76. (PMID: 26748091)
PLoS One. 2013;8(3):e58429. (PMID: 23533586)
Front Biosci (Landmark Ed). 2012 Jan 01;17(2):607-20. (PMID: 22201764)
Cell Mol Life Sci. 1999 Dec;56(11-12):991-1000. (PMID: 11212330)
Eur J Neurosci. 2006 Jun;23(11):2829-46. (PMID: 16819972)
Cell Death Dis. 2013 Jan 17;4:e461. (PMID: 23328668)
Acta Biochim Biophys Sin (Shanghai). 2018 Aug 1;50(8):831-833. (PMID: 29924300)
Sci Rep. 2021 Nov 3;11(1):21623. (PMID: 34732759)
Brain. 2006 Jul;129(Pt 7):1659-73. (PMID: 16672292)
Neuron. 2008 Dec 10;60(5):748-66. (PMID: 19081372)
J Neurochem. 1990 Sep;55(3):1067-70. (PMID: 2117046)
Nat Neurosci. 2005 Nov;8(11):1586-94. (PMID: 16234811)
Nat Rev Dis Primers. 2015 Nov 19;1:15071. (PMID: 27189754)
Cereb Cortex. 2017 Mar 1;27(3):2365-2384. (PMID: 27075036)
Arch Gen Psychiatry. 1987 Jul;44(7):660-9. (PMID: 3606332)
Proc Natl Acad Sci U S A. 2009 May 12;106(19):8043-8. (PMID: 19416912)
World J Biol Psychiatry. 2012 Oct;13(7):550-4. (PMID: 22385474)
J Affect Disord. 2009 Dec;119(1-3):177-80. (PMID: 19269692)
Front Neurosci. 2019 Dec 06;13:1301. (PMID: 31866811)
Curr Opin Neurobiol. 2001 Jun;11(3):387-94. (PMID: 11399439)
J Neurosci. 2019 May 1;39(18):3561-3581. (PMID: 30833507)
Neuropsychopharmacology. 2005 May;30(5):974-83. (PMID: 15726117)
Lancet Psychiatry. 2020 Mar;7(3):272-281. (PMID: 31704113)
Res Dev Disabil. 2013 May;34(5):1758-69. (PMID: 23506790)
Int J Dev Neurosci. 2011 May;29(3):283-94. (PMID: 20833244)
Hum Mol Genet. 1999 Nov;8(12):2229-37. (PMID: 10545603)
Medicine (Baltimore). 2011 Jan;90(1):1-18. (PMID: 21200182)
Behav Neurosci. 1992 Apr;106(2):274-85. (PMID: 1590953)
Nat Genet. 2008 Jun;40(6):751-60. (PMID: 18469815)
J Neurosci. 2021 Aug 4;41(31):6596-6616. (PMID: 34261699)
Mol Cell Neurosci. 2008 Nov;39(3):439-51. (PMID: 18775783)
Prog Brain Res. 2008;169:145-58. (PMID: 18394472)
J Neurochem. 2010 Sep;114(6):1745-55. (PMID: 20626558)
Proc Natl Acad Sci U S A. 2017 Jul 25;114(30):E6127-E6136. (PMID: 28696314)
J Neurosci. 2001 Nov 1;21(21):8417-25. (PMID: 11606630)
J Neurosci. 2007 Sep 19;27(38):10196-209. (PMID: 17881525)
Nat Rev Neurosci. 2005 Aug;6(8):626-40. (PMID: 16025096)
Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7612-6. (PMID: 7644464)
Am J Psychiatry. 2010 Oct;167(10):1178-93. (PMID: 20810471)
J Neurochem. 2014 May;129(4):591-601. (PMID: 24471494)
Mol Psychiatry. 2020 Aug;25(8):1704-1717. (PMID: 31925327)
Glia. 2018 Oct;66(10):2188-2199. (PMID: 30144319)
Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14608-13. (PMID: 9405660)
Nat Genet. 2004 Jul;36(7):725-31. (PMID: 15184899)
Brain. 2021 Jun 22;144(5):1351-1360. (PMID: 33876226)
Science. 2001 Jan 26;291(5504):657-61. (PMID: 11158678)
Neuroscience. 2016 May 26;323:43-61. (PMID: 25862587)
Res Dev Disabil. 2009 Jul-Aug;30(4):763-73. (PMID: 19070990)
Arch Gen Psychiatry. 1999 Oct;56(10):940-5. (PMID: 10530637)
Harv Rev Psychiatry. 2009;17(3):214-25. (PMID: 19499420)
Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16859-64. (PMID: 12477929)
Neuropsychopharmacology. 2016 Aug;41(9):2411-20. (PMID: 27103065)
Eur J Neurosci. 2012 Jun;35(12):1871-8. (PMID: 22708598)
Neuron. 2003 Oct 9;40(2):389-400. (PMID: 14556716)
Am J Med Genet. 2000 Spring;97(1):45-51. (PMID: 10813803)
Nat Neurosci. 2007 Mar;10(3):331-9. (PMID: 17310248)
J Biol Chem. 1999 Jul 2;274(27):19473-1979. (PMID: 10383464)
Science. 1992 May 1;256(5057):675-7. (PMID: 1585183)
Dev Psychopathol. 2005 Summer;17(3):753-84. (PMID: 16262991)
Nature. 2010 Nov 11;468(7321):232-43. (PMID: 21068832)
Nat Neurosci. 2004 Jun;7(6):613-20. (PMID: 15156145)
Hum Mol Genet. 2001 Nov 1;10(23):2645-50. (PMID: 11726551)
J Child Neurol. 2004 May;19(5):337-42. (PMID: 15224707)
Int J Dev Neurosci. 2002 Jun-Aug;20(3-5):407-19. (PMID: 12175881)
Schizophr Res. 2004 Oct 1;70(2-3):223-32. (PMID: 15329299)
Nat Clin Pract Endocrinol Metab. 2007 Dec;3(12):827-34. (PMID: 18026161)
Neuropsychopharmacology. 2008 Jan;33(1):18-41. (PMID: 17728696)
Nat Neurosci. 1998 Aug;1(4):318-23. (PMID: 10195166)
Curr Opin Pharmacol. 2016 Feb;26:138-45. (PMID: 26707767)
J Neurosci. 2008 Jan 2;28(1):264-78. (PMID: 18171944)
Trends Neurosci. 2013 Jul;36(7):405-17. (PMID: 23659852)
Nat Rev Neurosci. 2002 Oct;3(10):791-802. (PMID: 12360323)
Nihon Shinkei Seishin Yakurigaku Zasshi. 2003 Aug;23(4):171-8. (PMID: 13677912)
Psychol Med. 2019 Apr;49(6):1047-1054. (PMID: 30064532)
Nature. 1996 Feb 15;379(6566):606-12. (PMID: 8628395)
Cell Rep. 2021 Apr 13;35(2):108952. (PMID: 33852851)
Nat Genet. 1999 Apr;21(4):434-9. (PMID: 10192398)
Mol Psychiatry. 2017 Dec;22(12):1664-1672. (PMID: 28761081)
Nat Rev Neurosci. 2008 Jan;9(1):65-75. (PMID: 18094707)
Cell. 2019 Sep 5;178(6):1387-1402.e14. (PMID: 31474363)
Proc Natl Acad Sci U S A. 2011 Mar 15;108(11):4447-52. (PMID: 21368174)
Transl Psychiatry. 2020 Jan 28;10(1):41. (PMID: 32066701)
Nat Rev Neurosci. 2010 Mar;11(3):161-75. (PMID: 20168314)
J Neurosci. 2007 Jun 13;27(24):6473-7. (PMID: 17567808)
Biol Psychiatry. 2001 Dec 1;50(11):825-44. (PMID: 11743939)
Brain Res. 2002 May 17;936(1-2):58-67. (PMID: 11988230)
J Mol Model. 2010 Jun;16(6):1151-8. (PMID: 20013137)
Nat Rev Neurosci. 2010 Jun;11(6):402-16. (PMID: 20485365)
Neuron. 2016 Jan 6;89(1):37-53. (PMID: 26687838)
J Neurochem. 2001 Oct;79(1):130-42. (PMID: 11595765)
Curr Opin Neurobiol. 2004 Jun;14(3):318-27. (PMID: 15194112)
Cell Rep. 2018 Jan 2;22(1):269-285. (PMID: 29298427)
J Am Acad Child Adolesc Psychiatry. 2013 Nov;52(11):1192-1203.e3. (PMID: 24157393)
Cold Spring Harb Perspect Biol. 2012 Mar 01;4(3):. (PMID: 22258914)
Cell Metab. 2011 Dec 7;14(6):724-38. (PMID: 22152301)
Cell Transplant. 2019 Sep-Oct;28(9-10):1173-1182. (PMID: 31161783)
Mol Autism. 2017 Oct 27;8:58. (PMID: 29090080)
Transl Psychiatry. 2017 Aug 22;7(8):e1214. (PMID: 28892071)
Neuroscientist. 2010 Feb;16(1):40-50. (PMID: 20236948)
Hum Mol Genet. 2007 Jan 1;16(1):83-91. (PMID: 17135275)
Am J Psychiatry. 2020 Jul 1;177(7):589-600. (PMID: 32046535)
Am J Psychiatry. 2014 Jun;171(6):627-39. (PMID: 24577245)
Nat Rev Neurosci. 2013 May;14(5):311-21. (PMID: 23595014)
Oncotarget. 2012 Oct;3(10):1220-35. (PMID: 23100451)
J Neurosci. 2002 Jan 1;22(1):183-92. (PMID: 11756501)
Glia. 2013 Jun;61(6):905-16. (PMID: 23505051)
Int J Dev Neurosci. 2011 May;29(3):259-81. (PMID: 20920576)
J Neurosci. 2012 Oct 10;32(41):14132-44. (PMID: 23055483)
Int Rev Neurobiol. 2009;85:261-93. (PMID: 19607976)
Int J Mol Sci. 2015 Jan 07;16(1):1312-35. (PMID: 25574603)
Nature. 2010 Apr 1;464(7289):763-7. (PMID: 20360742)
Am J Clin Nutr. 2009 Sep;90(3):875S-880S. (PMID: 19571222)
Annu Rev Neurosci. 2000;23:649-711. (PMID: 10845078)
Nature. 2006 Feb 2;439(7076):604-7. (PMID: 16452979)
Am J Hum Genet. 1997 Sep;61(3):620-9. (PMID: 9326327)
Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):486-91. (PMID: 24297907)
Transl Psychiatry. 2021 Oct 21;11(1):545. (PMID: 34675186)
Nat Rev Neurosci. 2001 Mar;2(3):185-93. (PMID: 11256079)
Cell. 2003 Dec 26;115(7):787-98. (PMID: 14697198)
Science. 2014 Mar 28;343(6178):1485-1489. (PMID: 24675956)
Nat Rev Neurosci. 2007 Dec;8(12):935-47. (PMID: 17987031)
Pharmacol Rev. 2004 Sep;56(3):331-49. (PMID: 15317907)
Hum Mol Genet. 2004 Dec 1;13(23):2991-5. (PMID: 15489219)
J Neurosci. 2004 Sep 29;24(39):8410-5. (PMID: 15456813)
Neurochem Int. 2004 Sep;45(4):521-7. (PMID: 15186918)
Neurosci Res. 2021 Jun;167:17-29. (PMID: 33316304)
Schizophr Res. 2006 Jun;84(2-3):187-93. (PMID: 16545541)
Science. 2013 Jan 11;339(6116):197-200. (PMID: 23307741)
Curr Opin Neurobiol. 2005 Oct;15(5):542-8. (PMID: 16144764)
Proc Natl Acad Sci U S A. 2006 Nov 7;103(45):16906-11. (PMID: 17077150)
Front Synaptic Neurosci. 2014 Nov 25;6:28. (PMID: 25505409)
J Neurosci. 2004 May 12;24(19):4551-9. (PMID: 15140926)
J Am Acad Child Adolesc Psychiatry. 2006 Sep;45(9):1104-1113. (PMID: 16926618)
Neuron. 2019 Jun 19;102(6):1127-1142.e3. (PMID: 31079872)
Schizophr Res. 2006 Oct;87(1-3):270-8. (PMID: 16753283)
Neurochem Int. 2010 Nov;57(4):440-5. (PMID: 20193723)
J Neurosci. 2008 Dec 3;28(49):13161-72. (PMID: 19052207)
J Neurosci. 2010 Nov 24;30(47):15843-55. (PMID: 21106823)
Neurochem Int. 1998 Jul;33(1):11-22. (PMID: 9694037)
Neuron. 2014 Feb 19;81(4):728-39. (PMID: 24559669)
Am J Psychiatry. 2003 Mar;160(3):469-76. (PMID: 12611827)
Genes Dev. 2004 Dec 15;18(24):3016-27. (PMID: 15574589)
J Neurosci. 2013 Sep 11;33(37):14825-39. (PMID: 24027283)
Mol Psychiatry. 2012 Sep;17(9):926-39. (PMID: 21769100)
Lancet. 2002 Feb 2;359(9304):426-30. (PMID: 11844533)
Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3717-22. (PMID: 11891283)
Cell. 2001 Feb 23;104(4):619-29. (PMID: 11239417)
Cereb Cortex. 2015 May;25(5):1143-51. (PMID: 24217989)
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14433-8. (PMID: 14614146)
Neuron. 2015 May 6;86(3):680-95. (PMID: 25913858)
Cell. 2013 Jan 17;152(1-2):262-75. (PMID: 23332760)
Neuropsychologia. 2008 Jan 15;46(1):82-94. (PMID: 17920087)
Trends Neurosci. 2009 Aug;32(8):421-31. (PMID: 19615761)
Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):18976-81. (PMID: 19033200)
Schizophr Bull. 2009 May;35(3):549-62. (PMID: 19325164)
Brain Res. 2007 Mar 30;1139:48-59. (PMID: 17292336)
J Nerv Ment Dis. 1994 Aug;182(8):476-8. (PMID: 8040660)
Curr Opin Neurobiol. 2007 Feb;17(1):103-11. (PMID: 17275283)
Mol Psychiatry. 2020 Apr;25(4):732-749. (PMID: 30127471)
JAMA Psychiatry. 2015 Apr;72(4):377-85. (PMID: 25715178)
Am J Psychiatry. 2003 Sep;160(9):1580-6. (PMID: 12944331)
Curr Opin Neurobiol. 2014 Feb;24(1):176-89. (PMID: 24419141)
Nature. 1999 Sep 23;401(6751):379-83. (PMID: 10517636)
Eur Neuropsychopharmacol. 2016 Oct;26(10):1610-8. (PMID: 27524298)
Am J Psychiatry. 2000 Mar;157(3):409-15. (PMID: 10698817)
Mol Psychiatry. 2017 Sep;22(9):1313-1326. (PMID: 27184122)
Eur J Biochem. 2000 Oct;267(20):6102-9. (PMID: 11012661)
Nat Neurosci. 2018 Oct;21(10):1412-1420. (PMID: 30224804)
Nat Rev Neurosci. 2009 Dec;10(12):842-9. (PMID: 19888283)
Neuron. 2017 Nov 1;96(3):697-708. (PMID: 29096081)
Neuroscience. 2004;129(4):877-96. (PMID: 15561405)
Nat Neurosci. 2007 Mar;10(3):376-84. (PMID: 17277774)
Prog Neurobiol. 2015 Jul;130:1-28. (PMID: 25866365)
Adv Exp Med Biol. 2012;970:307-31. (PMID: 22351062)
Curr Opin Neurobiol. 2018 Feb;48:139-145. (PMID: 29316489)
معلومات مُعتمدة: GGP20037 Telethon Foundation
فهرسة مساهمة: Keywords: 22q11 deletion syndrome; astrocytes; mitochondria; synapses; synaptic plasticity
المشرفين على المادة: 0 (Mitochondrial Proteins)
تواريخ الأحداث: Date Created: 20220423 Date Completed: 20220426 Latest Revision: 20220716
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC9028090
DOI: 10.3390/ijms23084412
PMID: 35457231
قاعدة البيانات: MEDLINE